Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
about
Silicosis appears inevitable among former denim sandblasters: a 4-year follow-up studyPirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse eventsIs there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathwayComputed tomography imaging of a leopard tortoise (Geochelone pardalis pardalis) with confirmed pulmonary fibrosis: a case report.Idiopathic pulmonary fibrosis: the need for early diagnosisAtorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway.Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition.Identifying the benefits and risks of emerging treatments for idiopathic pulmonary fibrosis: a qualitative study.Pirfenidone-induced severe phototoxic reaction in a patient with idiopathic lung fibrosis.Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis.Pirfenidone in respirable powder form for the treatment of pulmonary fibrosis: a safer alternative to the current oral delivery system?Radiographic and histopathologic characteristics of pulmonary fibrosis in nine cats.Epidemiology of Rare Lung Diseases: The Challenges and Opportunities to Improve Research and Knowledge.Pirfenidone for the treatment of idiopathic pulmonary fibrosis.Pirfenidone-induced photo-allergic reaction in a patient with idiopathic pulmonary fibrosis.The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis.Pirfenidone-induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis.
P2860
Q23918200-0767C2A7-C8BD-4D06-AED5-8BB57A3C2640Q26824810-10319A5D-4262-4C5A-8954-4766B4A55453Q26998459-11CCC352-FA67-442F-A7E6-A0217624ACB7Q36141637-BFCD319F-69B5-4FAF-B5A8-F6732D0B9F56Q36808631-FF6C05A7-DB6D-4785-B524-377E8DB0D36EQ37152292-86048277-EFD6-4A16-A997-D1B9144692C5Q37421028-AE4B19CD-C0E8-4B96-BB31-875F810E38F6Q38698129-F7A0674F-3427-4CD4-833B-0166B491CB19Q39150547-B845C746-360F-4E5E-B451-FBA73D7FE821Q40112892-E8860628-0D53-4902-A73A-6779CD03CE24Q41636898-EF7AC526-D72F-494A-8C34-0A187BD0464AQ44623296-6A2C95F3-3AC2-4F04-86AD-1883883CA63AQ46985817-2280A28F-6E23-4E4A-BE0A-D3C13608EFB6Q47656318-71647FDA-234C-40F2-A27D-39D69C6249A0Q48068644-64EE8880-5A65-4816-805E-96ED4106A669Q48165520-C98C1A5C-87E4-495B-832A-BFE004A17271Q50069018-343C85C1-C528-4309-A66A-2EC640A2B402Q53450652-ABDEDAF6-4133-4CFA-8E3E-D75AE0D72228
P2860
Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Changing the idiopathic pulmon ...... and improving patient outcomes
@ast
Changing the idiopathic pulmon ...... and improving patient outcomes
@en
Changing the idiopathic pulmon ...... and improving patient outcomes
@nl
type
label
Changing the idiopathic pulmon ...... and improving patient outcomes
@ast
Changing the idiopathic pulmon ...... and improving patient outcomes
@en
Changing the idiopathic pulmon ...... and improving patient outcomes
@nl
prefLabel
Changing the idiopathic pulmon ...... and improving patient outcomes
@ast
Changing the idiopathic pulmon ...... and improving patient outcomes
@en
Changing the idiopathic pulmon ...... and improving patient outcomes
@nl
P3181
P1476
Changing the idiopathic pulmon ...... and improving patient outcomes
@en
P2093
P3181
P356
10.1183/09059180.00001112
P407
P577
2012-06-01T00:00:00Z